help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on June 9, 2009
Journal of Clinical Endocrinology & Metabolism , doi:10.1210/jc.2009-0766
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
94/9/3365    most recent
Author Manuscript (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Reprints, Permissions and Rights
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Barahona, M.-J.
Right arrow Articles by Webb, S. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Barahona, M.-J.
Right arrow Articles by Webb, S. M.
Related Collections
Right arrow Adrenal and Hypertension
Right arrow Neuroendocrinology and Pituitary
Right arrow Metabolism

Submitted on April 8, 2009
Accepted on June 1, 2009

PERSISTENT BODY FAT MASS AND INFLAMMATORY MARKER INCREASES AFTER LONG-TERM CURE OF CUSHING'S SYNDROME

María-José Barahona*, Nuria Sucunza, Eugenia Resmini, José-Manuel Fernández-Real, Wifredo Ricart, José-María Moreno-Navarrete, Teresa Puig, Jordi Farrerons, and Susan M. Webb

Endocrinology and Medicine Departments and Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBER-ER, Unidad 747), ISCIII, Barcelona, Hospital Sant Pau, Universitat Autònoma de Barcelona; Endocrinology Department, Institut d'Investigació Biomèdica de Girona (IDIBGI) and CIBER Fisiopatologia de la Obesidad y Nutrición CB06/03/010; Hospital Josep Trueta, Girona; Epidemiology and Internal Medicine Departments, Hospital Sant Pau, Universitat Autònoma de Barcelona, Spain

* To whom correspondence should be addressed. E-mail: 33962mbc{at}comb.cat.

Objective: Although increased central fat mass is characteristic of active Cushing's syndrome (CS), little is known on body composition and secretion of adipokines after long-term recovery of CS. The aim was to evaluate central fat mass and its correlation with adipokines and cardiovascular risk factors in patients after long-term remission of CS.

Methods: Thirty-seven women with CS in remission (27 of pituitary and 10 of adrenal origin, mean age: 50 ± 14 years, mean time of hormonal cure: 11 ± 6 years) were enrolled and compared to 14 with active CS and 85 gender, age and BMI-matched healthy controls. Total and trunk fat mass were measured by dual-energy x-ray absorptiometry scanning. Laboratory parameters and adipokine levels [including adiponectin, visfatin, soluble TNF{alpha}-receptor 1 (sTNF-R1), sTNF-R2 and IL-6] were measured.

Results: Cured CS patients had more total and trunk fat mass than controls. Cured and active CS had higher levels of sTNF-R1 and IL-6, and lower adiponectin levels than controls. Higher insulin levels and blood pressure in both groups of CS patients and higher apoprotein B in cured CS were observed compared to controls. sTNF-R1 correlated positively with percentage of trunk fat mass, and remained significant after adjusting for anthropometric parameters.

Conclusion: Despite long-term cure, patients who have suffered CS exhibit persistent accumulation of central fat, as in active hypercortisolemia, with the consequent unfavourable adipokine profile, leading to a state of low-grade inflammation. This situation determines a persistent and increased cardiovascular risk in these patients.


Key words: Cushing's syndrome • fat mass • inflammation




This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
S. M. Webb, D. Mo, S. W. J. Lamberts, S. Melmed, F. Cavagnini, F. Pecori Giraldi, C. J. Strasburger, A. G. Zimmermann, W. W. Woodmansee, and on behalf of the International HypoCCS Advisory Bo
Metabolic, Cardiovascular, and Cerebrovascular Outcomes in Growth Hormone-Deficient Subjects with Previous Cushing's Disease or Non-Functioning Pituitary Adenoma
J. Clin. Endocrinol. Metab., February 1, 2010; 95(2): 630 - 638.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2009 by The Endocrine Society